Results 191 to 200 of about 92,115 (273)

Immune checkpoint inhibitors with neoadjuvant chemoradiotherapy in proficient MMR rectal cancer: systematic review and meta-analysis. [PDF]

Radiat Oncol
Ghalehtaki R, Abyaneh R, Aghaei MM, Mahmoudi F, Arab A, Seddighi N, Kolahdouzan K.   +6 more
europepmc   +1 more source

Preoperative Neutrophil‐to‐Lymphocyte Ratio Predicts Recurrence in HPV‐Associated Oropharyngeal Cancer After Transoral Robotic Surgery

Otolaryngology–Head and Neck Surgery, Volume 175, Issue 3, Page 650-656, September 2026.
Abstract Objective Evaluate the role of preoperative neutrophil‐to‐lymphocyte ratio (NLR) as a predictor of survival outcomes after transoral robotic surgery (TORS) for human papillomavirus‐related (HPV+) oropharyngeal squamous cell carcinoma (OPSCC).
Micah K. Harris, Kelly Daniels, Vanessa Helou, Katie Carlson, Shivam D. Patel, Elizabeth Sell, Matthew E. Spector, Jose P. Zevallos, Joshua D. Smith, Jessica H. Maxwell, Seungwon Kim, Shaum S. Sridharan, Kevin J. Contrera   +12 more
wiley   +1 more source

Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives

Precision Medical Sciences, Volume 15, Issue 3, Page 206-226, September 2026.
Graphical abstract represents the risk factors for lung cancer, TCM efficacy and clinical outcomes to future challenges. Abstract Lung cancer remains a leading cause of global cancer mortality. Despite advances in conventional treatments such as surgery, chemotherapy, targeted therapy, and immunotherapy, challenges including drug resistance, toxicity ...
Zhangdeng Chen, Liujun Bao
wiley   +1 more source

Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. [PDF]

Transl Cancer Res
Li Y, Liu J, Yu W, Song XY, Cai XW, Wang GZ, Fu XL.   +6 more
europepmc   +1 more source

Guideline concordance of stage IIIA non‐small‐cell lung cancer treatment in the Australian setting

Internal Medicine Journal, Volume 56, Issue 9, Page 1593-1599, September 2026.
Abstract Background Stage IIIA non‐small‐cell lung cancer (NSCLC) is a life‐limiting disease, and the level of adherence to evidence‐based treatment guidelines in the Australian setting is unclear. Aim To assess the level of adherence to stage IIIA NSCLC treatment guidelines prior to the advent of immunotherapy and highlight factors that may contribute
Georgia Ross, Matthew Conron, Gavin Wright, Eve Denton   +3 more
wiley   +1 more source

Tertiary lymphoid structures predict outcomes of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. [PDF]

BMC Cancer
Huang TC, Liang CW, Li YI, Guo JC, Lin CC, Chao YK, Shen WC, Cheng AL, Hsu CH.   +8 more
europepmc   +1 more source

Advances in therapeutic approaches to gastric cancer

CA: A Cancer Journal for Clinicians, Volume 76, Issue 5, September/October 2026.
Abstract Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with nearly 1 million new cases diagnosed annually. Despite innovations in diagnosis, most patients still present at advanced stages, contributing to a poor prognosis.
Feng Wang, Zi‐Xian Wang, Yu‐Jing Zhang, Ye He, Jia‐Fu Ji, Yuan‐Fang Li, Xiu‐Juan Qu, Yi Ba, Shu‐Qiang Yuan, Rui‐Hua Xu   +9 more
wiley   +1 more source

Association of Pretreatment Immune-Inflammatory Biomarkers with Pathological Tumor Regression Following Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. [PDF]

J Clin Med
Ergin AS, Cakan Demirel B, Bedir S, Sünnetci Arıkan N, Saylar A, Karabulut A, Bugdayci N, Özcan TB, Pasaoglu HE.   +8 more
europepmc   +1 more source

Tumor stroma-immune interactions shape the immunosuppressive microenvironment and predict response to neoadjuvant chemoradiotherapy plus immunotherapy in rectal cancer. [PDF]

J Immunother Cancer
Wang Q, Tian N, Guo H, Xiang Y, Xiao Y, Lin G, Zhang G, Xu L, Lu J, Chen G, Cai H, Du X, Du J, Wu B.   +13 more
europepmc   +1 more source

Integrating genetic and transcriptomics data to predict neoadjuvant chemoradiotherapy for patients with esophageal squamous cell carcinoma. [PDF]

J Thorac Dis
Li T, Li H, Ye X, Hu Y.
europepmc   +1 more source